Venus Remedies informs about press release

25 Feb 2025 Evaluate
Venus Remedies has informed that it enclosed a press release titled ‘Venus Remedies secures exclusive In-Licensing rights from Infex Therapeutics to develop and commercialize MET-X in India’.

The above information is a part of company’s filings submitted to BSE.

Venus Remedies Share Price

784.80 7.30 (0.94%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×